BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8599743)

  • 21. Cryptic exposure to arsenic.
    Rossy KM; Janusz CA; Schwartz RA
    Indian J Dermatol Venereol Leprol; 2005; 71(4):230-5. PubMed ID: 16394429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Skin symptoms in chronic occupational arsenic poisoning].
    Hamada T; Horiguchi S
    Nihon Rinsho; 1977 Feb; 35(2):430-3. PubMed ID: 140255
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic arsenicism with vitiligo, hyperthyroidism, and cancer.
    Bickley LK; Papa CM
    N J Med; 1989 May; 86(5):377-80. PubMed ID: 2739949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cutaneous arsenical cancer in viticultivators in Beaujolais].
    Thiers H; Colomb D; Moulin G; Colin L
    Ann Dermatol Syphiligr (Paris); 1967; 94(2):133-58. PubMed ID: 4228712
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid onset of multiple concurrent squamous cell carcinomas associated with the use of an arsenic-containing traditional medicine for chronic plaque psoriasis.
    Siefring ML; Lu D; States JC; Van Hoang M
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29602886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy.
    Hsu LI; Chen GS; Lee CH; Yang TY; Chen YH; Wang YH; Hsueh YM; Chiou HY; Wu MM; Chen CJ
    Am J Epidemiol; 2013 Feb; 177(3):202-12. PubMed ID: 23299695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin cancer caused by chronic arsenical poisoning--a report of three cases.
    Jaafar R; Omar I; Jidon AJ; Wan-Khamizar BW; Siti-Aishah BM; Sharifah-Noor-Akmal SH
    Med J Malaysia; 1993 Mar; 48(1):86-92. PubMed ID: 8341178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bowen's disease of ocular localization caused by chronic exposure to arsenic].
    Jordano J; Carreras B; Serrano D; Guirao A
    Rev Clin Esp; 1978 Oct; 151(1):57-61. PubMed ID: 740972
    [No Abstract]   [Full Text] [Related]  

  • 29. [Morphogenesis and variety of precancerous lesions induced by arsenic].
    Hundeiker M; Petres J
    Arch Klin Exp Dermatol; 1968 May; 231(4):355-65. PubMed ID: 4235142
    [No Abstract]   [Full Text] [Related]  

  • 30. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia.
    Guo X; Liu Z; Huang C; You L
    J Health Popul Nutr; 2006 Jun; 24(2):214-20. PubMed ID: 17195562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic as a cause of skin cancer, with notes on its occurrence in Pretoria.
    Schulz EJ
    S Afr Med J; 1967 Sep; 41(33):819-22. PubMed ID: 6060318
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bowen's disease with multiple lesions caused by chronic arsenic poisoning].
    Giménez H; Agurruza JM; Martínez G; Grasa MP; Carapeto FJ
    Actas Dermosifiliogr; 1980; 71(9-10):337-42. PubMed ID: 7223522
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin.
    Kennedy C; Bajdik CD; Willemze R; Bouwes Bavinck JN
    Br J Dermatol; 2005 Jan; 152(1):194-7. PubMed ID: 15656837
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical and histological studies on the problem of drug-induced arsenic tumors].
    Ehlers G
    Z Haut Geschlechtskr; 1968 Sep; 43(18):763-74. PubMed ID: 4886760
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutaneous malignant and premalignant conditions caused by chronic arsenicosis from contaminated ground water consumption: a profile of patients from eastern India.
    Ghosh SK; Bandyopadhyay D; Bandyopadhyay SK; Debbarma K
    Skinmed; 2013; 11(4):211-6. PubMed ID: 24053006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
    Koh E; Kondoh N; Kaihara H; Fujioka H; Kitamura K
    Eur Urol; 1989; 16(5):398-400. PubMed ID: 2776813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infrequent p53 mutations in arsenic-related skin lesions.
    Castrén K; Ranki A; Welsh JA; Vähäkangas KH
    Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic.
    Torchia D; Massi D; Caproni M; Fabbri P
    Int J Dermatol; 2008 Jun; 47(6):592-3. PubMed ID: 18477152
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic arsenic poisoning from the viewpoint of the dermatologist].
    Hums R
    Dermatol Monatsschr; 1983; 169(12):765-75. PubMed ID: 6667759
    [No Abstract]   [Full Text] [Related]  

  • 40. Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies.
    Rossman TG; Uddin AN; Burns FJ; Bosland MC
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):749-52. PubMed ID: 12426125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.